source
- FDA confronts surge of Chinese biotech firms as they become key industry playersThe FDA is currently assessing how to handle the rapid growth of biotech companies from China, which have moved from being economic competitors to important contributors in the pharmaceutical lands…
- UK parliamentary committees demand probe into cost of US-UK pharma trade dealSix UK parliamentary committees have written to the relevant watchdog asking for an investigation into the cost of the United Kingdom's pharmaceutical trade agreement with the United States. The c…